Although the detailed interactions and regulatory mechanisms between MAD2B and Numb still need to be clarified, therapeutic approaches to specifically modulate MAD2B-mediated Numb-dependent Notch1 pathway in the kidneys may prevent or halt the progression of DN (Figure 8). The gene discussed is NOTCH1; the disease is liver dysplastic nodule.